Figure 4.
Placebo response rates in trials using proton pump inhibitors versus trials using H2-receptor antagonists. The placebo response rate among patients receiving PPI therapy was borderline significantly lower than the response rate among patients taking H2-receptor antagonists (14.5% vs. 24.7%, respectively; p =0.05).